Use of botulinum toxin in children with cerebral palsy
Monika Stecko, Agata Wawryków, Katarzyna Korabiusz and 2 more
Journal of Education, Health and Sport · 2019
doi:10.5281/zenodo.3354824 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Cerebral palsy in children is a syndrome of disorders resulting from damage to the central nervous system in its early development [1]. Damage to the structure of the upper motor neuron during its early development leads to dysfunction of the central motor control system and, consequently, to impairment of the child’s functional development [2,3]. The consequences of damage to the central motor control system include the presence of muscular tension disorders, especially spasticity [4,5]. Botulinum toxin is one of the many pharmacological agents used to reduce spasticity. Botulinum toxin therapy is one of the most effective and currently safest methods for the treatment of spasticity in children [6].
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.